MiMedx Group (NASDAQ: MDXG) revenue
MiMedx Group reported revenue of $418.6m for fiscal 2025, 20.0% more than in fiscal 2024 ($348.9m). Since fiscal 2016 its revenue has grown by 88.8%, an average growth of 7.3% a year.
MiMedx Group has grown its revenue for 4 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2020, −17.0%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $418.6m | +20.0% | $63.9m | 15.3% |
| 2024 | $348.9m | +8.5% | $58.9m | 16.9% |
| 2023 | $321.5m | +20.0% | $37.1m | 11.5% |
| 2022 | $267.8m | +10.7% | −$14.7m | −5.5% |
| 2021 | $242.0m | −2.5% | −$7.1m | −2.9% |
| 2020 | $248.2m | −17.0% | −$45.4m | −18.3% |
| 2019 | $299.3m | −16.7% | −$21.2m | −7.1% |
| 2018 | $359.1m | +11.8% | −$3.9m | −1.1% |
| 2017 | $321.1m | +44.8% | $46.2m | 14.4% |
| 2016 | $221.7m | — | $0.9m | 0.4% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
MiMedx Group revenue compared with its sector
By revenue for its latest fiscal year, MiMedx Group ranks 202nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; MiMedx Group, 20.0%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 200th | GeneDx | $427.5m | 40.0% |
| 201st | Certara | $418.8m | 8.7% |
| 202nd | MiMedx Group | $418.6m | 20.0% |
| 203rd | Innoviva | $411.3m | 14.7% |
| 204th | Ardelyx | $407.3m | 22.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of MiMedx Group
- How much revenue did MiMedx Group make in fiscal 2025?
- MiMedx Group reported revenue of $418.6m for fiscal 2025, compared with $348.9m in fiscal 2024.
- How much has the revenue of MiMedx Group grown?
- Between fiscal 2016 and fiscal 2025 it went from $221.7m to $418.6m: 88.8% more, an average growth of 7.3% a year.
- What was the best year for revenue at MiMedx Group?
- Of its last 10 fiscal years, fiscal 2025, with $418.6m.
- Where does MiMedx Group rank in its sector by revenue?
- It ranks 202nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for MiMedx Group come from?
- From the annual report (Form 10-K) that MiMedx Group files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that MiMedx Group files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on MiMedx Group: the MiMedx Group page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.